Featured Research

from universities, journals, and other organizations

Game-changing shift occurring in cancer discovery, treatment

Date:
December 11, 2013
Source:
American Society of Clinical Oncology
Summary:
Research advances that have come to fruition over the past year demonstrate extraordinary progress in the fight against cancer, according to a new report. The report stresses, however, that recent budget cuts and years-long flat funding can only delay efforts to translate research into effective treatments for millions of individuals with cancer.

Research advances that have come to fruition over the past year demonstrate extraordinary progress in the fight against cancer, according to a new report released today by the American Society of Clinical Oncology (ASCO). The report stresses, however, that recent budget cuts and years-long flat funding can only delay efforts to translate research into effective treatments for millions of individuals with cancer.

Clinical Cancer Advances 2013: ASCO's Annual Report on Progress Against Cancer reveals how marked expansion in our knowledge and understanding of cancer is already improving treatment while also pointing the way towards even more effective approaches in the future. Published today in the Journal of Clinical Oncology, the ASCO report covers a broad range of cancer types and highlights a selection of the most recent achievements across the entire continuum of cancer care, from prevention and screening to treatment and survivorship.

"For patients today, these results can be critical. Scientifically, they demonstrate how our long term investment in science and technology can yield practical advances now and in the near future," said ASCO President Clifford A. Hudis, MD, FACP. "With these reports, we are witnessing the acceleration of our shift into a new era of medicine in which our knowledge of the molecular basis and activity of cancers leads to ever more precise treatments that offer increased efficacy and reduced toxicities. The research progress just this year in so many cancers is proof that targeted, precision medicine is now a reality for an increasing number of patients."

The 76 advances highlighted in this year's Clinical Cancer Advances report represent intriguing singular developments in cancer research. However, ASCO notes that it is what these advances represent collectively that gives tremendous hope to anyone who receives a cancer diagnosis in the future. Three areas of progress, in particular, provide important new insights into cancer care:

  • Genomics -- new research demonstrated how understanding the genetic make-up of cancer is already helping doctors make better, more individualized treatment decisions, as well as how it will guide future drug discovery and development.
  • Treatment-resistant cancers -- new research produced first-ever effective therapies for cancers that have historically been especially resistant.
  • Targeted immunotherapy -- new research showed how we can harness patients' own immune system to effectively treat a growing number of cancer types.

"Our report catalogues the most significant gains made in oncology, as identified by leading experts in the field," said Jyoti Patel, MD, the report's co-executive editor. "Building on prior decades of critical, foundational research, this year revealed remarkable progress on a wide range of cancers, including some cancers for which there had been frustratingly limited success over decades. The advances highlighted in this report translate to improvements in patient outcomes and will allow doctors to better predict which drugs will improve survival for which patients."

This year's Clinical Cancer Advances also offers an overview of the policy developments and issues critical to the future of cancer research in this country. The report states that progress against cancer -- and the recent strides in improving patient care, survival, and quality of life -- were due, in large measure, to our nation's investment in cancer research over the past four decades. Since the 1990s, cancer death rates have declined 21 percent among men and 12 percent among women.

But, with an estimated 1.6 million Americans diagnosed with cancer this year, about 580,000 American lives lost to cancer in 2013, and associated with a growing, aging, and more overweight population that makes it likely that cancer will become the leading cause of death by 2030, (with an increase of 40% in the total number of new cancer cases), the need to identify new, effective treatments will continue to intensify.

"As a nation, we face an escalating problem with previously unimaginable tools. Now, we can either let the incredible momentum we're witnessing in cancer progress stall, or we can support biomedical studies that will help people with cancer live longer and with a better quality of life," said ASCO President Hudis. "To accelerate the pace of this important research, we're asking Congress to do its part to re-ignite our nation's commitment to cancer research. Lives depend on it."

ASCO is seeking at least $32 billion in funding for the NIH in 2014 to sustain current projects. The Society is also calling on Congress to reverse the federal budget sequester that triggered across-the-board cuts to cancer research in the United States. The sequester, combined with flat research funding over the last decade, has caused the purchasing power of the National Institutes of Health to fall by 23 percent in inflation-adjusted dollars since 2003.


Story Source:

The above story is based on materials provided by American Society of Clinical Oncology. Note: Materials may be edited for content and length.


Journal Reference:

  1. J. D. Patel, L. Krilov, S. Adams, C. Aghajanian, E. Basch, M. S. Brose, W. L. Carroll, M. de Lima, M. R. Gilbert, M. G. Kris, J. L. Marshall, G. A. Masters, S. J. O'Day, B. Polite, G. K. Schwartz, S. Sharma, I. Thompson, N. J. Vogelzang, B. J. Roth. Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. Journal of Clinical Oncology, 2013; DOI: 10.1200/JCO.2013.53.7076

Cite This Page:

American Society of Clinical Oncology. "Game-changing shift occurring in cancer discovery, treatment." ScienceDaily. ScienceDaily, 11 December 2013. <www.sciencedaily.com/releases/2013/12/131211132501.htm>.
American Society of Clinical Oncology. (2013, December 11). Game-changing shift occurring in cancer discovery, treatment. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2013/12/131211132501.htm
American Society of Clinical Oncology. "Game-changing shift occurring in cancer discovery, treatment." ScienceDaily. www.sciencedaily.com/releases/2013/12/131211132501.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

House Republicans Vote to Sue Obama Over Healthcare Law

House Republicans Vote to Sue Obama Over Healthcare Law

Reuters - US Online Video (July 31, 2014) The Republican-led House of Representatives votes to sue President Obama, accusing him of overstepping his executive authority in making changes to the Affordable Care Act. Mana Rabiee reports. Video provided by Reuters
Powered by NewsLook.com
Despite Health Questions, E-Cigs Are Beneficial: Study

Despite Health Questions, E-Cigs Are Beneficial: Study

Newsy (July 31, 2014) Citing 81 previous studies, new research out of London suggests the benefits of smoking e-cigarettes instead of regular ones outweighs the risks. Video provided by Newsy
Powered by NewsLook.com
Dangerous Bacteria Kills One in Florida

Dangerous Bacteria Kills One in Florida

AP (July 31, 2014) Sarasota County, Florida health officials have issued a warning against eating raw oysters and exposing open wounds to coastal and inland waters after a dangerous bacteria killed one person and made another sick. (July 31) Video provided by AP
Powered by NewsLook.com
Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins